Neurol. praxi. 2017;18(4):279-282 | DOI: 10.36290/neu.2017.098

Mechanical thrombectomy after the standard time window

MUDr. Ing. David Černík, MBA1, 3, MUDr. Andrea Prcúchová1, 3, MUDr. Filip Cihlář, Ph.D2, doc. MUDr. Daniel Šaňák, Ph.D., FESO3
1 KCC, Neurologie, Masarykova nemocnice Ústí nad Labem
2 Radiodiagnostické odd., Masarykova nemocnice Ústí nad Labem
3 KCC, Neurologická klinika LF UP a FN Olomouc

Introduction: Mechanical thrombectomy is recommended standard treatment of occluded large cerebral artery within first 6hours since stroke onset. Beyond this standard therapeutic time window, thrombectomy may be beneficial in strictly selectedpatients only and upper treatment time limit has been still unknown. The aim was to document a positive clinical effect of thrombectomyperformed after 14 hours since stroke onset.

Methods: We describe a case of 73 y/o female, who presented with sudden severe left-sided hemiparesis at home. Shewas admitted to the stroke center after eleven hours after stroke onset with severe and fluctuating hemiparesis. AdmissionCT scan showed partial occlusion of right internal carotid artery (ICA) and occlusion middle cerebral artery (MCA) and relativelylarge ischemic penumbra on CT perfusion scans. Based on clinical symptoms, CT and MRI findings the mechanicalthrombectomy with successful recanalization of ICA and MCA was performed 14 hours after stroke onset with an excellentclinical outcome.

Conclusion: Mechanical thrombectomy is recommended a standard treatment of occluded large cerebral artery within first 6hours since stroke onset. Strictly selected patients with ischemic penumbral patterns may have benefit from mechanical thrombectomyeven beyond standard therapeutic time window.

Keywords: ischemic stroke, occlusion of internal carotid artery, occlusion of middle cerebral artery, mechanical thrombectomy

Published: October 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Černík D, Prcúchová A, Cihlář F, Šaňák D. Mechanical thrombectomy after the standard time window. Neurol. praxi. 2017;18(4):279-282. doi: 10.36290/neu.2017.098.
Download citation

References

  1. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ, van Walderveen MA, Staals J, Hofmeijer J, van Oostayen JA, Lycklama ? Nijeholt GJ, Boiten J, Brouwer PA, Emmer BJ, de Bruijn SF, van Dijk LC, Kappelle LJ, Lo RH, van Dijk EJ, de Vries J, de Kort PL, van Rooij WJ, van den Berg JS, van Hasselt BA, Aerden LA, Dallinga RJ, Visser MC, Bot JC, Vroomen PC, Eshghi O, Schreuder TH, Heijboer RJ, Keizer K, Tielbeek AV, den Hertog HM, Gerrits DG, van den Berg-Vos RM, Karas GB, Steyerberg EW, Flach HZ, Marquering HA, Sprengers ME, Jenniskens SF, Beenen LF, van den Berg R, Koudstaal PJ, van Zwam WH, Roos YB, van der Lugt A, van Oostenbrugge RJ, Majoie CB, Dippel DW; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke., N Engl J Med. 2015 Jan 1; 372(1): 11-20. Go to original source... Go to PubMed...
  2. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, Yan B, Dowling RJ, Parsons MW, Oxley TJ, Wu TY, Brooks M, Simpson MA, Miteff F, Levi CR, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Priglinger M, Ang T, Scroop R, Barber PA, McGuinness B, Wijeratne T, Phan TG, Chong W, Chandra RV, Bladin CF, Badve M, Rice H, de Villiers L, Ma H, Desmond PM, Donnan GA, Davis SM; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection, N Engl J Med. 2015 Mar 12; 372(11): 1009-1018. Go to original source... Go to PubMed...
  3. Cerebrovaskulární sekce České neurologické společnosti ČLS JEP; Doporučený postup pro intravenózní trombolýzu v léčbě akutního mozkového infarktu - verze 2014, Cesk Slov Neurol N 2014; 77/ 110(3): 381-385.
  4. Cerebrovaskulární sekce České neurologické společnosti ČLS JEP; Doporučení pro rekanalizační léčbu akutního mozkového infarktu - verze 2016, Cesk Slov Neurol N 2016; 79/ 112(2): 231-234.
  5. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, Roy D, Jovin TG, Willinsky RA, Sapkota BL, Dowlatshahi D, Frei DF, Kamal NR, Montanera WJ, Poppe AY, Ryckborst KJ, Silver FL, Shuaib A, Tampieri D, Williams D, Bang OY, Baxter BW, Burns PA, Choe H, Heo JH, Holmstedt CA, Jankowitz B, Kelly M, Linares G, Mandzia JL, Shankar J, Sohn SI, Swartz RH, Barber PA, Coutts SB, Smith EE, Morrish WF, Weill A, Subramaniam S, Mitha AP, Wong JH, Lowerison MW, Sajobi TT, Hill MD; ESCAPE Trial Investigators. Randomized assessment of Rapid endovascular treatment of ischemic stroke. N Engl J Med 2015; 372: 1019-1030. Go to original source... Go to PubMed...
  6. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, San Román L, Serena J, Abilleira S, Ribó M, Millán M, Urra X, Cardona P, López-Cancio E, Tomasello A, Casta?o C, Blasco J, Aja L, Dorado L, Quesada H, Rubiera M, Hernandez-Pérez M, Goyal M, Demchuk AM, von Kummer R, Gallofré M, Dávalos A; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015 Jun 11; 372(24): 2296-2306. Go to original source... Go to PubMed...
  7. Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG, Wilder MJ, Lutsep HL, Czartoski TJ, Bernstein RA, Chang CW, Warach S, Fazekas F, Inoue M, Tipirneni A, Hamilton SA, Zaharchuk G, Marks MP, Bammer R, Albers GW; DEFUSE 2 study investigators. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 2012; 11: 860-867. Go to original source... Go to PubMed...
  8. Lansberg MG, Cereda CW, Mlynash M, Mishra NK, Inoue M, Kemp S, Christensen S, Straka M, Zaharchuk G, Marks MP, Bammer R, Albers GW; Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution 2 (DEFUSE 2) Study Investigators. Neurology. 2015 Aug 25; 85(8): 708-714. Go to original source... Go to PubMed...
  9. Mourand I, Milhaud D, Arquizan C, Lobotesis K, Schaub R, Machi P, Ayrignac X, Eker OF, Bonafé A, Costalat V. Favorable bridging therapy based on DWI-FLAIR mismatch in patients with unclear-onset stroke. AJNR Am J Neuroradiol. 2016; 37(1): 88-93. Go to original source... Go to PubMed...
  10. Natarajan SK, Snyder KV, Siddiqui AH, Ionita CC, Hopkins LN, Levy EI. Safety and effectiveness of endovascular therapy after 8 hours of acute Ischemic stroke onset and wake-up strokes. Stroke, 2009 Oct; 40(10): 3269-3274. Go to original source... Go to PubMed...
  11. Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, Albers GW, Cognard C, Cohen DJ, Hacke W, Jansen O, Jovin TG, Mattle HP, Nogueira RG, Siddiqui AH, Yavagal DR, Baxter BW, Devlin TG, Lopes DK, Reddy VK, du Mesnil de Rochemont R, Singer OC, Jahan R; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015; 372: 2285-2295. Go to original source... Go to PubMed...
  12. The European Stroke Organisation (ESO) Executive Committee a the ESO Writing Committee; Guidelines for Management of Ischaemic Stroke 2008, Update 2009, Available from URL: http://www.eso-stroke.org/eso-stroke/education/guidelines.html (accessed 20 Jun 2016).
  13. van der Hoeven EJ, Schonewille WJ, Vos JA, Algra A, Audebert HJ, Berge E, Ciccone A, Mazighi M, Michel P, Muir KW, Obach V, Puetz V, Wijman CA, Zini A, Kappelle JL; BASICS Study Group. The Basilar Artery International Cooperation Study (BASICS): study protocol for a randomised controlled trial. Trials. 2013 Jul 8; 14: 200. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.